Co-Diagnostics, Inc. Makes Strategic Additions to Scientific Advisory Board
Co-Diagnostics, Inc. Makes Strategic Additions to Scientific Advisory Board […]
Co-Diagnostics, Inc. Makes Strategic Additions to Scientific Advisory Board […]
Myriad to establish new Walter Gilbert Research and Innovation Center Company also cited among 2022 Top Workplaces USA National List by Energage […]
BRACAnalysis CDx is now the only germline test approved by FDA as a companion diagnostic for treatment of HER2 negative high-risk early-stage breast cancer […]
Company launches Precise™ Tumor test, part of a comprehensive suite combining germline, tumor and companion diagnostics in one easy-to-access solution […]
Acquisition offers new, differentiated, and potentially best-in-class approach to address needs of a broader number of patients with immuno-inflammatory diseases […]
PolarityTE Announces $5.0 Million Registered Direct Offering […]
The Senate HELP Committee on Tuesday voted 20-2 to advance legislation, the PREVENTS Pandemic Act. […]
Co-Diagnostics announced that its Board of Directors has authorized a share repurchase program that would allow the Company to repurchase up to $30 million of CODX common stock. […]
Legislation would combat corrupt Chinese Courts from issuing “anti-suit injunctions” that prevent companies from challenging patent infringement from Chinese companies in American courts. […]
Xenter has leased 30,000 square feet to accommodate explosive growth in the new Irvine Office Park in Draper, Utah. […]
myIntelX will be launching in conjunction with KidneyIntelX going live at Atrium Health, and will expand testing services across all Renalytix healthcare provider partners […]
IONIQ Sciences announced that it has acquired from OT Acceptance, LLC certain intellectual property formerly licensed to the Company by OT Acceptance. […]